Naperville, IL, United States of America

Ridong Chen

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Maryland Heights, MO (US) (2005 - 2013)
  • Naperville, IL (US) (2007 - 2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Ridong Chen: Innovator in Apyrase Therapeutics

Introduction

Ridong Chen is a prominent inventor based in Naperville, IL (US), known for his significant contributions to the field of therapeutic apyrases. With a total of 10 patents to his name, Chen has made remarkable advancements in the development of apyrase agents and their applications in medical treatments.

Latest Patents

Chen's latest patents include groundbreaking inventions such as "Therapeutic apyrase constructs, apyrase agents, and production methods." This invention introduces a new class of enhanced apyrases (EN-apyrases) that exhibit superior pharmacokinetic, pharmacodynamic, and pharmacochemical properties. The EN-apyrases can be purified using simplified procedures, and the invention also provides constructs for transforming cells to produce these EN-apyrases. Additionally, Chen has developed methods for producing apyrase in culture cells and purifying it effectively.

Another notable patent is "Apyrase therapy for bleeding conditions." This invention outlines new methods for treating individuals experiencing or at risk of bleeding due to vascular injury, particularly in the microvasculature and/or platelet desensitization. The apyrase agents are designed to address various pathophysiological conditions, including ischemia reperfusion injury and injuries caused by pharmacologic agents. Furthermore, these agents are beneficial in maintaining organ function during transplantation.

Career Highlights

Throughout his career, Ridong Chen has worked with notable companies such as Apt Therapeutics, Inc. and Monsanto Technology LLC. His work in these organizations has contributed to the advancement of therapeutic innovations and the application of apyrase technology in clinical settings.

Collaborations

Chen has collaborated with esteemed colleagues, including Soon Seog Jeong and Timothy A Mitsky. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.

Conclusion

Ridong Chen's contributions to the field of apyrase therapeutics highlight his role as a leading inventor in medical innovation. His patents and collaborative efforts continue to pave the way for advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…